Champions Oncology Inc

-0.18 (-3.54%)
4:00:05 PM EDT: $4.91 0.00 (0.00%)
Twitter Share  Facebook Share StockTwits Share

Search For a Symbol

Market Cap (Intraday)66.74M
Current PEN/A
Forward PE N/A
2yr Forward PE N/A
See more stats
Estimates Current Quarter
Revenue$12.7 Million
Adjusted EPS-$0.16
See more estimates
10-Day MA$4.90
50-Day MA$4.85
200-Day MA$5.48
See more pivots

Champions Oncology Inc Stock, NASDAQ:CSBR

One University Plaza, Suite 307, Hackensack, New Jersey 07601
United States of America
Phone: +1.201.808.8400
Number of Employees: 230


Champions Oncology, Inc. engages in the development and sale of technology solutions and products to personalize the development and use of oncology drugs. Its technology platform, TumorGraft, is a novel approach to personalizing cancer care based upon the implantation of human tumors in immune-deficient mice. The company was founded by James M. Martell and David Sidransky on June 4, 1985 and is headquartered in Hackensack, NJ.